Title : Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe.

Pub. Date : 2016 Dec

PMID : 27714510






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 By potently inhibiting the Niemann-Pick C1-Like 1 (NPC1L1) sterol receptor on intestinal enterocytes and within the liver, ezetimibe blocks exogenous cholesterol absorption and has been shown to improve biochemical markers of NAFLD, improve insulin sensitivity and decrease hepatic steatosis. Ezetimibe insulin Homo sapiens